Login / Signup
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.
Sunil Kumar Joshi
Jamie M Keck
Christopher A Eide
Daniel Bottomly
Elie Traer
Jeffrey W Tyner
Shannon K McWeeney
Cristina E Tognon
Brian J Druker
Published in:
Leukemia (2020)
Keyphrases
</>
acute myeloid leukemia
bone marrow
tyrosine kinase